These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36400408)

  • 21. Genomic Surveillance Reveals Diversity of Multidrug-Resistant Organism Colonization and Infection: A Prospective Cohort Study in Liver Transplant Recipients.
    Macesic N; Gomez-Simmonds A; Sullivan SB; Giddins MJ; Ferguson SA; Korakavi G; Leeds D; Park S; Shim K; Sowash MG; Hofbauer M; Finkel R; Hu Y; West J; Toussaint NC; Greendyke WG; Miko BA; Pereira MR; Whittier S; Verna EC; Uhlemann AC
    Clin Infect Dis; 2018 Aug; 67(6):905-912. PubMed ID: 29718144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of multidrug-resistant organisms in nursing homes in Belgium in 2015.
    Latour K; Huang TD; Jans B; Berhin C; Bogaerts P; Noel A; Nonhoff C; Dodémont M; Denis O; Ieven M; Loens K; Schoevaerdts D; Catry B; Glupczynski Y
    PLoS One; 2019; 14(3):e0214327. PubMed ID: 30921364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The fight to keep resistance at bay, epidemiology of carbapenemase producing organisms (CPOs), vancomycin resistant enterococci (VRE) and methicillin resistant Staphylococcus aureus (MRSA) in Norway, 2006 - 2017.
    Elstrøm P; Astrup E; Hegstad K; Samuelsen Ø; Enger H; Kacelnik O
    PLoS One; 2019; 14(2):e0211741. PubMed ID: 30716133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contamination of Common Area and Rehabilitation Gym Environment with Multidrug-Resistant Organisms.
    Gontjes KJ; Gibson KE; Lansing B; Cassone M; Mody L
    J Am Geriatr Soc; 2020 Mar; 68(3):478-485. PubMed ID: 31851386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of multidrug-resistant Gram-negative bacteria carriage in children screened prospectively for multidrug resistant organisms at admission to a paediatric hospital, Hamburg, Germany, September 2018 to May 2019.
    Najem S; Eick D; Boettcher J; Aigner A; Aboutara M; Fenner I; Reinshagen K; Koenigs I
    Euro Surveill; 2022 Apr; 27(15):. PubMed ID: 35426366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multi-Resistant Bacteria in Patients in Hospitals and Medical Practices as well as in Residents of Nursing Homes in Saxony - Results of a Prevalence Study 2017/2018].
    Sommer L; Hackel T; Hofmann A; Hoffmann J; Hennebach E; Köpke B; Sydow W; Ehrhard I; Chaberny IF
    Gesundheitswesen; 2021 Sep; 83(8-09):624-631. PubMed ID: 32380560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bloodstream infections and multidrug resistant bacteria acquisition among burns patients in Australia and New Zealand: A registry-based study.
    Cleland H; Stewardson A; Padiglione A; Tracy L
    Burns; 2024 Aug; 50(6):1544-1554. PubMed ID: 38714428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for colonization by carbapenemase-producing bacteria in Spanish long-term care facilities: a multicentre point-prevalence study.
    Callejón Fernández M; Madueño Alonso A; Abreu Rodríguez R; Aguirre-Jaime A; Castro Hernández MB; Ramos-Real MJ; Pedroso-Fernández Y; Lecuona Fernández M
    Antimicrob Resist Infect Control; 2022 Dec; 11(1):163. PubMed ID: 36536455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of contact precautions for multidrug-resistant organisms in the post-COVID-19 pandemic era: An updated national Emerging Infections Network (EIN) survey.
    Howard-Anderson JR; Gottlieb LB; Beekmann SE; Polgreen PM; Jacob JT; Uslan DZ
    Infect Control Hosp Epidemiol; 2024 Jun; 45(6):703-708. PubMed ID: 38351872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving hospital hygiene to reduce the impact of multidrug-resistant organisms in health care--a prospective controlled multicenter study.
    Gerlich MG; Piegsa J; Schäfer C; Hübner NO; Wilke F; Reuter S; Engel G; Ewert R; Claus F; Hübner C; Ried W; Flessa S; Kramer A; Hoffmann W
    BMC Infect Dis; 2015 Oct; 15():441. PubMed ID: 26493394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of deduplication on the detection rates of multidrug-resistant organism (MDRO) in various specimens: insights from the hospital infection surveillance program.
    Li Z; Zhu D; Ma X; Zang F; Zhang W; Luo C; Zhu C; Chen W; Zhu P
    Antimicrob Resist Infect Control; 2024 May; 13(1):54. PubMed ID: 38769515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of tailored screening for multidrug-resistant organisms upon admission to an intensive care unit in the United Arab Emirates.
    Park S; Kim H; Gatchalian KK; Oh H
    Antimicrob Resist Infect Control; 2023 Nov; 12(1):135. PubMed ID: 38012753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and risk factors associated with multi-drug resistant organisms (MDRO) carriage among pediatric patients at the time of admission in a tertiary care hospital of a developing country. A cross-sectional study.
    Qureshi S; Maria N; Zeeshan M; Irfan S; Qamar FN
    BMC Infect Dis; 2021 Jun; 21(1):547. PubMed ID: 34107903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations and guidelines for the treatment of infections due to multidrug resistant organisms.
    Sy CL; Chen PY; Cheng CW; Huang LJ; Wang CH; Chang TH; Chang YC; Chang CJ; Hii IM; Hsu YL; Hu YL; Hung PL; Kuo CY; Lin PC; Liu PY; Lo CL; Lo SH; Ting PJ; Tseng CF; Wang HW; Yang CH; Lee SS; Chen YS; Liu YC; Wang FD
    J Microbiol Immunol Infect; 2022 Jun; 55(3):359-386. PubMed ID: 35370082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs.
    Ma X; Wu Y; Li L; Xu Q; Hu B; Ni Y; Wu A; Sun S; Jarlier V; Robert J
    BMC Infect Dis; 2015 Aug; 15():358. PubMed ID: 26290050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Reducing Antibiotics on the Transmission of Multidrug-Resistant Organisms.
    Barnes SL; Rock C; Harris AD; Cosgrove SE; Morgan DJ; Thom KA
    Infect Control Hosp Epidemiol; 2017 Jun; 38(6):663-669. PubMed ID: 28270258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands.
    van Dulm E; Tholen ATR; Pettersson A; van Rooijen MS; Willemsen I; Molenaar P; Damen M; Gruteke P; Oostvogel P; Kuijper EJ; Hertogh CMPM; Vandenbroucke-Grauls CMJE; Scholing M
    PLoS One; 2019; 14(9):e0222200. PubMed ID: 31513682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current prevalence of multidrug-resistant organisms in long-term care facilities in the Rhine-Main district, Germany, 2013.
    Hogardt M; Proba P; Mischler D; Cuny C; Kempf VA; Heudorf U
    Euro Surveill; 2015 Jul; 20(26):. PubMed ID: 26159310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colonization of long-term care facility residents in three Italian Provinces by multidrug-resistant bacteria.
    Nucleo E; Caltagirone M; Marchetti VM; D'Angelo R; Fogato E; Confalonieri M; Reboli C; March A; Sleghel F; Soelva G; Pagani E; Aschbacher R; Migliavacca R; Pagani L; ;
    Antimicrob Resist Infect Control; 2018; 7():33. PubMed ID: 29527303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.